Lixte Biotechnology Holdings, Inc. - LIXT
About Gravity Analytica
Recent News
- 09.10.2025 - LIXTE Biotechnology Holdings Makes $2.6 Million Initial Purchase of Digital Currency to Diversify Treasury and for Potential Acquisitions
- 09.03.2025 - LIXTE Biotechnology Holdings Appoints Two New Board Members and New Chief Financial Officer
- 08.25.2025 - 24/7 Market News: LIXTE Targets Large, Unmet Oncology Markets
- 08.18.2025 - LIXTE Biotechnology Holdings Provides Corporate Update
- 08.14.2025 - 24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with Multiple Phase 1B/2 Trial Readouts Expected in 2H 2025
- 08.13.2025 - 24/7 Market News: LIXTE Biotechnology Holdings Embraces Cryptocurrency in Corporate Treasury Strategy
- 08.13.2025 - LIXTE Biotechnology Holdings Updates Corporate Treasury Policy to Include Cryptocurrency
Recent Filings
- 09.10.2025 - 3 Initial statement of beneficial ownership of securities
- 09.04.2025 - EX-99.1 EX-99.1
- 09.04.2025 - 3 Initial statement of beneficial ownership of securities
- 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.04.2025 - 3 Initial statement of beneficial ownership of securities
- 09.04.2025 - 8-K Current report
- 08.19.2025 - EX-99.1 EX-99.1
- 08.19.2025 - 8-K Current report
- 08.18.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.18.2025 - 4 Statement of changes in beneficial ownership of securities